The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
Open accessAbstract
BACKGROUND: A malaria vaccine could be an important addition to current control strategies. We report the safety and vaccine efficacy (VE) of the RTS,S/AS01 vaccine during 18 mo following vaccination at 11 African sites with varying malaria transmission. METHODS AND FINDINGS: 6,537 infants aged 6-12 wk and 8,923 children aged 5-17 mo were randomized to receive three doses of RTS,S/AS01 or comparator vaccine. VE against clinical malaria in children during the 18 mo after vaccine dose 3 (per protocol) was 46% (95% CI 42% to 50%) (range 40% to 77%; VE, p<0.01 across all sites). VE during the 20 mo after vaccine dose 1 (intention to treat [ITT]) was 45% (95% CI 41% to 49%). VE against severe malaria, malaria hospitalization, and all-cause hospitalization was 34% (95% CI 15% to 48%), 41% (95% CI 30% to 50%), and 19% (95% CI 11% to 27%), respectively (ITT). VE against clinical malaria in infants was 27% (95% CI 20% to 32%, per protocol; 27% [95% CI 21% to 33%], ITT), with no significant protection against severe malaria, malaria hospitalization, or all-cause hospitalization. Post-vaccination anti-circumsporozoite antibody geometric mean titer varied from 348 to 787 EU/ml across sites in children and from 117 to 335 EU/ml in infants (per protocol). VE waned over time in both age categories (Schoenfeld residuals p<0.001). The number of clinical and severe malaria cases averted per 1,000 children vaccinated ranged across sites from 37 to 2,365 and from -1 to 49, respectively; corresponding ranges among infants were -10 to 1,402 and -13 to 37, respectively (ITT). Meningitis was reported as a serious adverse event in 16/5,949 and 1/2,974 children and in 9/4,358 and 3/2,179 infants in the RTS,S/AS01 and control groups, respectively. CONCLUSIONS: RTS,S/AS01 prevented many cases of clinical and severe malaria over the 18 mo after vaccine dose 3, with the highest impact in areas with the greatest malaria incidence. VE was higher in children than in infants, but even at modest levels of VE, the number of malaria cases averted was substantial. RTS,S/AS01 could be an important addition to current malaria control in Africa. TRIAL REGISTRATION: www.ClinicalTrials.gov NCT00866619 Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Insecticide-treated bed nets and curtains for preventing malaria
Lengeler, C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000363.pub2 · Cited by 1,700
Global malaria mortality between 1980 and 2010: a systematic analysis
Murray, C. J., Rosenfeld, L. C., Lim, S. S., Andrews, K. G., Foreman, K. J., Haring, D., Fullman, N., Naghavi, M., Lozano, R., & Lopez, A. D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60034-8 · Cited by 1,452 · cited 1×
“Considerable gains have been made in the control of malaria during the past decade as a result of improved diagnosis, introduction of effective treatment with artemisinin combination therapy (ACT), and widespread deployment of insecticide-treated nets (ITNs) [1,2].”
BackgroundA new world malaria map: Plasmodium falciparum endemicity in 2010
Gething, P. W., Patil, A. P., Smith, D. L., Guerra, C. A., Elyazar, I. R., Johnston, G. L., Tatem, A. J., & Hay, S. I. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-378 · Cited by 1,146
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
The RTS, S. C. T. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102287 · Cited by 896
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
The RTS, S. C. T. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208394 · Cited by 752
Bojang, K. A., Milligan, P. J., Pinder, M., Vigneron, L., Alloueche, A., Kester, K. E., Ballou, W. R., Conway, D. J., Reece, W. H., Gothard, P., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06957-4 · Cited by 528
Kester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
A World Malaria Map: Plasmodium falciparum Endemicity in 2007
Hay, S. I., Guerra, C. A., Gething, P. W., Patil, A. P., Tatem, A. J., Noor, A. M., Kabaria, C. W., Manh, B. H., Elyazar, I. R. F., Brooker, S., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000048 · Cited by 505
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
Aponte, J. J., Aide, P., Renom, M., Mandomando, I., Bassat, Q., Sacarlal, J., Manaca, M. N., Lafuente, S., Barbosa, A., Leach, A., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61542-6 · Cited by 279
Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Awuondo, K. O., Leach, A., Lievens, M., Leboulleux, D., Njuguna, P., Peshu, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207564 · Cited by 270
Noor, A. M., Kinyoki, D. K., Mundia, C. W., Kabaria, C. W., Mutua, J. W., Alegana, V. A., Fall, I. S., & Snow, R. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62566-0 · Cited by 263
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Abdulla, S., Oberholzer, R., Juma, O., Kubhoja, S., Machera, F., Membi, C., Omari, S., Urassa, A., Mshinda, H., Jumanne, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807773 · Cited by 239
IMPAIRMENT OF THE IMMUNE RESPONSE TO VACCINATION AFTER ACUTE MALARIA
Williamson, W. A., & Greenwood, B. M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92403-0 · Cited by 208
Dauby, N., Goetghebuer, T., Kollmann, T. R., Levy, J., & Marchant, A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70341-3 · Cited by 179
Asante, K. P., Abdulla, S., Agnandji, S. T., Lyimo, J., Vekemans, J., Soulanoudjingar, S., Owusu, R., Shomari, M., Leach, A. J., Jongert, E., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70100-1 · Cited by 175
TER KUILE, F. O., TERLOUW, D. J., PHILLIPS-HOWARD, P. A., HAWLEY, W. A., FRIEDMAN, J. F., KOLCZAK, M. S., KARIUKI, S. K., SHI, Y. P., KWENA, A. M., VULULE, J. M., et al. (2003) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.100 · Cited by 166
Estimates of child deaths prevented from malaria prevention scale-up in Africa 2001-2010
Eisele, T. P., Larsen, D. A., Walker, N., Cibulskis, R. E., Yukich, J. O., Zikusooka, C. M., & Steketee, R. W. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-93 · Cited by 162
Greenwood, B. M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91949-6 · Cited by 147
Protopopoff, N., Matowo, J., Malima, R., Kavishe, R. A., Kaaya, R. D., Wright, A., West, P. A., Kleinschmidt, I., Kisinza, W. N., Mosha, F. W., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-149 · Cited by 146
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
Bejon, P., White, M. T., Olotu, A., Bojang, K., Lusingu, J., Salim, N., Otsyula, N., Agnandji, S. T., Asante, K. P., Owusu‐Agyei, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70005-7 · Cited by 128
Swysen, C., Vekemans, J., Bruls, M., Oyakhirome, S., DRAKELEY, C. J., Kremsner, P. G., Greenwood, B. M., Ofori‐Anyinam, O., Okech, B. A., Villafana, T. L., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-223 · Cited by 107
Lell, B., Agnandji, S. T., von Glasenapp, I., Haertle, S., Oyakhiromen, S., Issifou, S., Vekemans, J., Leach, A. J., Lievens, M., Dubois, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007611 · Cited by 95
Leach, A. J., Vekemans, J., Lievens, M., Ofori‐Anyinam, O., Cahill, C. P., Owusu‐Agyei, S., Abdulla, S., Macete, E., Njuguna, P., Savarese, B., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-224 · Cited by 85
Malaria Modifies Neonatal and Early-Life Toll-Like Receptor Cytokine Responses
Gbédandé, K., Varani, S., Ibitokou, S. A., Houngbégnon, P., Borgella, S., Nouatin, O. P., Ezinmègnon, S., Adeothy, A.-L., Cottrell, G., Massougbodji, A., et al. (2013) · Infection and Immunity · doi:10.1128/iai.00237-13 · Cited by 54
Clément, F., Dewar, V., Braeckel, E. V., Desombere, I., Dewerchin, M., Swysen, C., Demoitié, M., Jongert, E., Cohen, J., Leroux-Roels, G. G., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-384 · Cited by 46
Modeling the Development of Acquired Clinical Immunity to Plasmodium falciparum Malaria
Gatton, M. L., & Cheng, Q. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6538-6545.2004 · Cited by 45
Vekemans, J., Marsh, K., Greenwood, B. M., Leach, A. J., Kaboré, W., Soulanoudjingar, S., Asante, K. P., Ansong, D., Evans, J., Sacarlal, J., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-221 · Cited by 32
Cited by
Bache, E. B., Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B. P., Kabwende, A. L., Adégnika, A. A., Mordmüller, B. G., Kremsner, P. G., Loembé, M. M., et al. (2015) · The Lancet · doi:10.15496/publikation-6508 · Cited by 642
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Didierlaurent, A. M., Laupèze, B., Di Pasquale, A., Hergli, N., Collignon, C., & Garçon, N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1213632 · Cited by 516
Datoo, M. S., Natama, M. H., Somé, A., Traoré, O., Rouamba, T., Bellamy, D., Yameogo, P., Valia, D., Tegneri, M., Ouedraogo, F., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00943-0 · Cited by 452
Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection
Fernandez-Ruiz, D., Ng, W. Y., Holz, L. E., Ma, J. Z., Zaid, A., Wong, Y. C., Lau, L. S., Mollard, V., Cozijnsen, A., Collins, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.011 · Cited by 438
Metadata
- Authors
- The RTS, S. C. T. P. (.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-07-29
- Volume
- 11
- Issue
- 7
- Pages
- e1001685
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W65828984
- Cited by
- 474
- References
- 31
- FWCI
- 51.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.